Jiangsu Hengrui Medicine
600276.SS
S$11.45
Share price
2.84%
Change (1 day)
52.87%
Change (1 year)
Categories
Jiangsu Hengrui Medicine Company Limited is a Chinese pharmaceutical company engaged in the R&D, manufacturing and sales of healthcare products, including antineoplastic drugs, angiomyocardiac drugs, drugs for surgery, contrast agents and antibiotics
EPS for Jiangsu Hengrui Medicine (600276.SS)
EPS in 2025 (TTM): S$0.17
According to Jiangsu Hengrui Medicine 's latest financial reports the company's current EPS (TTM) is S$0.16. In 2024 the company made an earnings per share (EPS) of S$0.18 an increase over its 2023 EPS that were of S$0.12.
EPS history for Jiangsu Hengrui Medicine from 2000 to 2025
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2025 (TTM) | S$0.17 | -2.44% |
| 2024 | S$0.18 | 42.43% |
| 2023 | S$0.12 | 8.77% |
| 2022 | S$0.11 | -20.62% |
| 2021 | S$0.14 | -26.59% |
| 2020 | S$0.20 | 27.24% |
| 2019 | S$0.15 | 28.41% |
| 2018 | S$0.12 | 20.04% |
| 2017 | S$0.09964 | 31.21% |
| 2016 | S$0.07594 | 11.46% |
| 2015 | S$0.06813 | 36.27% |
| 2014 | S$0.05000 | 19.77% |
| 2013 | S$0.04174 | 18.05% |
| 2012 | S$0.03536 | 23.9% |
| 2011 | S$0.02854 | 26.9% |
| 2010 | S$0.02249 | 12.37% |
| 2009 | S$0.02002 | 56.6% |
| 2008 | S$0.01278 | 9.18% |
| 2007 | S$0.01171 | 114.48% |
| 2006 | S$0.005458 | 64.83% |
| 2005 | S$0.003312 | 35.55% |
| 2004 | S$0.002443 | 29.73% |
| 2003 | S$0.001883 | 19.86% |
| 2002 | S$0.001571 | -2.71% |
| 2001 | S$0.001615 | 1.02% |
| 2000 | S$0.001599 |